Healthcare provider profile · identity verified

Allison Flaherty

Family Practice · PITTSBURGH, PA · NPI 1134430937

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	231	67
Levothyroxine Sodium	Levothyroxine Sodium	119	32
Amlodipine Besylate	Amlodipine Besylate	112	29
Lisinopril	Lisinopril	112	36
Losartan Potassium	Losartan Potassium	95	28
Hydrochlorothiazide	Hydrochlorothiazide	80	23
Pantoprazole Sodium	Pantoprazole Sodium	70	22
Omeprazole	Omeprazole	69	20
Alendronate Sodium	Alendronate Sodium	64	16
Metformin Hcl Er	Metformin Hcl	64	20
Escitalopram Oxalate	Escitalopram Oxalate	60	17
Gabapentin	Gabapentin	58	15
Metoprolol Succinate	Metoprolol Succinate	56	18
Ozempic	Semaglutide	54	suppressed
Furosemide	Furosemide	51	17
Ibuprofen	Ibuprofen	50	12
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Metformin Hcl	Metformin Hcl	49	12
Metoprolol Tartrate	Metoprolol Tartrate	49	15
Oxycodone Hcl	Oxycodone Hcl	47	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Pregabalin	Pregabalin	45	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	45	13
Albuterol Sulfate Hfa	Albuterol Sulfate	44	12
Duloxetine Hcl	Duloxetine Hcl	43	13
Jardiance	Empagliflozin	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Meloxicam	Meloxicam	38	suppressed
Trazodone Hcl	Trazodone Hcl	37	11
Alprazolam	Alprazolam	36	suppressed
Trulicity	Dulaglutide	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	suppressed
Famotidine	Famotidine	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	13
Sertraline Hcl	Sertraline Hcl	30	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Clonazepam	Clonazepam	27	suppressed
Simvastatin	Simvastatin	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Eliquis	Apixaban	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Methylprednisolone	Methylprednisolone	22	16
Carvedilol	Carvedilol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Topiramate	Topiramate	19	suppressed
Valsartan	Valsartan	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	13
Amoxicillin	Amoxicillin	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Gralise	Gabapentin	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error